• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用参考方法校正的自然T值进行K值计算以诊断乳腺癌

K Calculation Using Reference Method Corrected Native T for Breast Cancer Diagnosis.

作者信息

Negi Pradeep Singh, Mehta Shashi Bhushan, Jena Amarnath, Rana Prerana

机构信息

PET Suite (Indraprastha Apollo Hospitals and House of Diagnostics), Department of Molecular Imaging and Nuclear Medicine, Indraprastha Apollo Hospitals, New Delhi, India.

Department of Physics, Vivekananda Global University, Jaipur, Rajasthan, India.

出版信息

J Med Phys. 2023 Jan-Mar;48(1):19-25. doi: 10.4103/jmp.jmp_90_22. Epub 2023 Apr 18.

DOI:10.4103/jmp.jmp_90_22
PMID:37342602
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10277302/
Abstract

PURPOSE

The objective of the study is to use multiple tube phantoms to generate correction factor at different spatial locations for each breast coil cuff to correct the native T value in the corresponding spatial location of the breast lesion. The corrected T value was used to compute K and analyze its diagnostic accuracy in the classification of target condition, i.e., breast tumors into malignant and benign.

MATERIALS AND METHODS

Both phantom study (external reference) and patient's studies were acquired on simultaneous positron emission tomography/magnetic resonance imaging (PET/MRI) Biograph molecular magnetic resonance (mMR) system using 4 channel mMR breast coil. The spatial correction factors derived using multiple tube phantom were used for a retrospective analysis of dynamic contrast-enhanced (DCE) MRI data of 39 patients with a mean age of 50 years (31-77 years) having 51 enhancing breast lesions.

RESULTS

Corrected and non-corrected receiver operating characteristic (ROC) curve analysis revealed a mean K value of 0.64 min and 0.60 min, respectively. The sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and overall accuracy for non-corrected data were 86.21%, 81.82%, 86.20%, 81.81%, and 84.31%, respectively, and for corrected data were 93.10%, 86.36%, 90%, 90.47%, and 90.20% respectively. The area under curve (AUC) of corrected data was improved to 0.959 (95% confidence interval [CI] 0.862-0.994) from 0.824 (95% CI 0.694-0.918) of non-corrected data, and for NPV, it was improved to 90.47% from 81.81%, respectively.

CONCLUSION

T values were normalized using multiple tube phantom which was used for computation of K. We found significant improvement in the diagnostic accuracy of corrected K values that results in better characterization of breast lesions.

摘要

目的

本研究的目的是使用多管体模为每个乳腺线圈套在不同空间位置生成校正因子,以校正乳腺病变相应空间位置的原始T值。校正后的T值用于计算K值,并分析其在目标疾病(即乳腺肿瘤良恶性分类)诊断中的准确性。

材料与方法

体模研究(外部参考)和患者研究均在使用4通道mMR乳腺线圈的同时正电子发射断层扫描/磁共振成像(PET/MRI)Biograph分子磁共振(mMR)系统上进行。使用多管体模得出的空间校正因子用于对39例平均年龄50岁(31 - 77岁)、有51个强化乳腺病变的患者的动态对比增强(DCE)MRI数据进行回顾性分析。

结果

校正后和未校正的受试者操作特征(ROC)曲线分析显示,平均K值分别为0.64分钟和0.60分钟。未校正数据的敏感性、特异性、阳性预测值(PPV)、阴性预测值(NPV)和总体准确率分别为86.21%、81.82%、86.20%、81.81%和84.31%,校正后数据的相应值分别为93.10%、86.36%、90%、90.47%和90.20%。校正后数据的曲线下面积(AUC)从未校正数据的0.824(95%置信区间[CI] 0.694 - 0.918)提高到0.959(95% CI 0.862 - 0.994),NPV从81.81%提高到90.47%。

结论

使用多管体模对T值进行标准化,用于计算K值。我们发现校正后的K值在诊断准确性方面有显著提高,从而能更好地对乳腺病变进行特征描述。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e8a/10277302/a9a7225d7226/JMP-48-19-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e8a/10277302/b19e244c6775/JMP-48-19-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e8a/10277302/ea0b0fd08017/JMP-48-19-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e8a/10277302/19866bfe7f1a/JMP-48-19-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e8a/10277302/a9a7225d7226/JMP-48-19-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e8a/10277302/b19e244c6775/JMP-48-19-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e8a/10277302/ea0b0fd08017/JMP-48-19-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e8a/10277302/19866bfe7f1a/JMP-48-19-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e8a/10277302/a9a7225d7226/JMP-48-19-g004.jpg

相似文献

1
K Calculation Using Reference Method Corrected Native T for Breast Cancer Diagnosis.使用参考方法校正的自然T值进行K值计算以诊断乳腺癌
J Med Phys. 2023 Jan-Mar;48(1):19-25. doi: 10.4103/jmp.jmp_90_22. Epub 2023 Apr 18.
2
Use of Multiple-Tube Phantom: A Method to Globally Correct Native T1 Relaxation Time Inhomogeneity in Dedicated Molecular Magnetic Resonance Breast Coil.多管体模的使用:一种全局校正专用分子磁共振乳腺线圈中固有T1弛豫时间不均匀性的方法。
J Med Phys. 2021 Jan-Mar;46(1):41-46. doi: 10.4103/jmp.JMP_2_20. Epub 2021 May 5.
3
Role of pharmacokinetic parameters derived with high temporal resolution DCE MRI using simultaneous PET/MRI system in breast cancer: A feasibility study.使用同步PET/MRI系统通过高时间分辨率DCE MRI得出的药代动力学参数在乳腺癌中的作用:一项可行性研究。
Eur J Radiol. 2017 Jan;86:261-266. doi: 10.1016/j.ejrad.2016.11.029. Epub 2016 Nov 25.
4
Role of quantitative pharmacokinetic parameter (transfer constant: K(trans)) in the characterization of breast lesions on MRI.定量药代动力学参数(转运常数:K(trans))在乳腺病变MRI特征描述中的作用。
Indian J Radiol Imaging. 2013 Jan;23(1):19-25. doi: 10.4103/0971-3026.113614.
5
High-temporal resolution DCE-MRI improves assessment of intra- and peri-breast lesions categorized as BI-RADS 4.高时间分辨率 DCE-MRI 提高了 BI-RADS 4 类乳腺内及周围病变的评估能力。
BMC Med Imaging. 2023 Apr 19;23(1):58. doi: 10.1186/s12880-023-01015-4.
6
Efficacy of high-resolution, 3-D diffusion-weighted imaging in the detection of breast cancer compared to dynamic contrast-enhanced magnetic resonance imaging.与动态对比增强磁共振成像相比,高分辨率三维扩散加权成像在乳腺癌检测中的效能
Pol J Radiol. 2021 May 10;86:e277-e286. doi: 10.5114/pjr.2021.106207. eCollection 2021.
7
[Diagnostic value of quantitative pharmacokinetic parameters and relative quantitative pharmacokinetic parameters in breast lesions with dynamic contrast-enhanced MRI].[动态对比增强磁共振成像定量药代动力学参数及相对定量药代动力学参数在乳腺病变中的诊断价值]
Zhonghua Yi Xue Za Zhi. 2017 Aug 1;97(29):2266-2270. doi: 10.3760/cma.j.issn.0376-2491.2017.29.007.
8
Diagnostic performance of ADC for Non-mass-like breast lesions on MR imaging.MR 成像中非肿块样乳腺病变 ADC 值的诊断性能。
Magn Reson Med Sci. 2010;9(4):217-25. doi: 10.2463/mrms.9.217.
9
Comparison of diffusion kurtosis imaging and dynamic contrast enhanced MRI in prediction of prognostic factors and molecular subtypes in patients with breast cancer.扩散峰度成像与动态对比增强 MRI 对乳腺癌患者预后因素和分子亚型预测的比较。
Eur J Radiol. 2022 Sep;154:110392. doi: 10.1016/j.ejrad.2022.110392. Epub 2022 Jun 3.
10
Blood Oxygenation Level Dependent Magnetic Resonance Imaging (MRI), Dynamic Contrast Enhanced MRI, and Diffusion Weighted MRI for Benign and Malignant Breast Cancer Discrimination: A Preliminary Experience.用于鉴别乳腺良恶性肿瘤的血氧水平依赖性功能磁共振成像(MRI)、动态对比增强MRI及扩散加权MRI:初步经验
Cancers (Basel). 2021 May 17;13(10):2421. doi: 10.3390/cancers13102421.

本文引用的文献

1
Use of Multiple-Tube Phantom: A Method to Globally Correct Native T1 Relaxation Time Inhomogeneity in Dedicated Molecular Magnetic Resonance Breast Coil.多管体模的使用:一种全局校正专用分子磁共振乳腺线圈中固有T1弛豫时间不均匀性的方法。
J Med Phys. 2021 Jan-Mar;46(1):41-46. doi: 10.4103/jmp.JMP_2_20. Epub 2021 May 5.
2
Association of pharmacokinetic and metabolic parameters derived using simultaneous PET/MRI: Initial findings and impact on response evaluation in breast cancer.使用同步正电子发射断层扫描/磁共振成像(PET/MRI)得出的药代动力学和代谢参数的关联:乳腺癌的初步研究结果及其对反应评估的影响
Eur J Radiol. 2017 Jul;92:30-36. doi: 10.1016/j.ejrad.2017.04.013. Epub 2017 Apr 23.
3
Simultaneous measurement of T /B and pharmacokinetic model parameters using active contrast encoding (ACE)-MRI.
使用主动对比编码(ACE)磁共振成像同时测量T/B和药代动力学模型参数。
NMR Biomed. 2017 Sep;30(9). doi: 10.1002/nbm.3737. Epub 2017 May 22.
4
Kinetic Analysis of Benign and Malignant Breast Lesions With Ultrafast Dynamic Contrast-Enhanced MRI: Comparison With Standard Kinetic Assessment.基于超快动态对比增强MRI的乳腺良恶性病变的动力学分析:与标准动力学评估的比较
AJR Am J Roentgenol. 2016 Nov;207(5):1159-1166. doi: 10.2214/AJR.15.15957. Epub 2016 Aug 17.
5
B Field Correction of T1 Estimation Should Be Considered for Breast Dynamic Contrast-enhanced MR Imaging Even at 1.5 T.即使在 1.5T 场强下,乳腺动态对比增强磁共振成像也应考虑 T1 估计的 B 场校正。
Radiology. 2017 Jan;282(1):55-62. doi: 10.1148/radiol.2016160062. Epub 2016 Aug 1.
6
Effect of Radiofrequency Transmit Field Correction on Quantitative Dynamic Contrast-enhanced MR Imaging of the Breast at 3.0 T.射频发射场校正对 3.0T 磁共振乳腺定量动态增强成像的影响。
Radiology. 2016 May;279(2):368-77. doi: 10.1148/radiol.2015150920. Epub 2015 Nov 16.
7
B1 and T1 mapping of the breast with a reference tissue method.采用参考组织法对乳腺进行B1和T1映射。
Magn Reson Med. 2016 Apr;75(4):1565-73. doi: 10.1002/mrm.25751. Epub 2015 May 27.
8
Quantitative analysis of 3-Tesla magnetic resonance imaging in the differential diagnosis of breast lesions.3特斯拉磁共振成像在乳腺病变鉴别诊断中的定量分析
Exp Ther Med. 2015 Mar;9(3):913-918. doi: 10.3892/etm.2014.2154. Epub 2014 Dec 22.
9
Feasibility of a fast method for B1-inhomogeneity correction for FSPGR sequences.用于FSPGR序列的B1不均匀性校正快速方法的可行性。
Magn Reson Imaging. 2015 Apr;33(3):312-8. doi: 10.1016/j.mri.2014.10.008. Epub 2014 Nov 11.
10
Clinical and technical considerations for high quality breast MRI at 3 Tesla.3.0T 磁共振乳腺成像的临床及技术要点
J Magn Reson Imaging. 2013 Apr;37(4):778-90. doi: 10.1002/jmri.23834.